Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2026 highlights: Astra, CSPC sign up to US$ 18.5 bn obesity deal; Wegovy’s pill version debuts in US

    Stock Recap
    #PipelineProspector

    Menu

    Oxantel Pamoate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 91Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Labeler NDC Package Code Non Proprietary Name Start Marketing Date End Marketing Date Category Code Dosage Form (Strength)
    27/02/2026 Minsheng Group Shaoxing Pharmaceutical
    China
    		 Minsheng Group Shaoxing Pharmaceutical Co., LTD. 13371-416 OXANTEL PAMOATE 2021-02-12 2026-12-31 BULK INGREDIENT POWDER (1kg/kg)
    27/02/2026 UQUIFA
    Spain
    		 Uquifa Mexico, S.A. de C.V. 52286-0026 Oxantel Pamoate 2017-12-01 2026-12-31 BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING POWDER (1kg/kg)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.